Low acylation stimulating protein levels are associated with cardiometabolic disorders-secondary to autoimmune activation?
ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.2, ss.97-106, 2017 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 2
- Basım Tarihi: 2017
- Doi Numarası: 10.14744/anatoljcardiol.2016.7024
- Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.97-106
- Anahtar Kelimeler: acylation stimulating protein, autoimmunity, type-2 diabetes, lipoprotein(a), metabolic syndrome, platelet activating factor, phospholipids, METABOLIC SYNDROME, PHOSPHOLIPASE A(2), COMPLEMENT C3, DISEASE, LIPIDS, DEFINITION, HUMANS, WOMEN, RISK
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Objective: We investigated the possible association of serum acylation stimulating protein (ASP) with cardiometabolic disorders and the evidence of autoimmune activation.